Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

ACRSACRS
Showing 3 of 8 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in ACLARIS THERAPEUTICS INC

WELLINGTON MANAGEMENT GROUP LLP holds 267,498 shares of ACRS (ACLARIS THERAPEUTICS INC), worth $1.4M as of 2026-Q2. The position was increased (+4.0% shares). ACRS represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$1.4M

Current Shares

267,498

Total Value Change

+$619,344

Total Shares Change

+3,139

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
267,498
+4.0%
$1.4M0.0%$5.29
27
2026-Q1
Decreased
257,156
-2.7%
$964,3350.0%$3.04
0
2025-Q4
New
264,359
-
$795,7200.0%$2.90
34

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used